Citeline

Citeline company information, Employees & Contact Information

Explore related pages

Related company profiles:

Citeline is a leading global provider of data, analytics, and insights to the life sciences and pharmaceutical industries. With a focus on accelerating drug development and improving clinical outcomes, Citeline empowers organizations to make data-driven decisions at every stage of the drug lifecycle. We offer innovative solutions in clinical trial data, drug development intelligence, regulatory insights, and competitive intelligence. Our services help pharmaceutical companies, contract research organizations (CROs), and biotech firms reduce risks, optimize resources, and increase the success rate of clinical trials. Our unique blend of advanced technology, expert analysis, and industry expertise is what sets us apart. We utilize AI-powered tools, curated databases, and expert-led research to provide actionable intelligence that drives business decisions. Citeline’s core offerings include: ClinicalTrials.gov Data: Providing real-time access to comprehensive global clinical trial data, enabling faster, more informed decisions. Drug Development Intelligence: In-depth research and insights on drug pipelines, market opportunities, and competitive dynamics to enhance strategic planning. Regulatory Intelligence: Streamlined insights on regulatory requirements, approval processes, and compliance to ensure seamless product development and market entry. Competitive Intelligence: Actionable insights into the competitive landscape, helping organizations stay ahead of emerging trends, opportunities, and potential risks. With years of experience in serving top pharmaceutical companies and organizations worldwide, we have earned a reputation for delivering accurate, timely, and reliable data solutions. Our customers trust us to help them navigate the complexities of drug development and stay competitive in a fast-evolving market. At Citeline, we’re committed to innovation, excellence, and collaboration.

Company Details

Employees
518
Address
New York, New York, Us
Industry
Information Services
NAICS
Other Information Services
News Syndicates
All Other Information Services
Keywords
New York.
HQ
New York, New York
Looking for a particular Citeline employee's phone or email?

Citeline Questions

News

Industry Excellence Celebrated At Citeline Japan Awards - Citeline News & Insights

Industry Excellence Celebrated At Citeline Japan Awards Citeline News & Insights

Deliberate Market Building Is Next Step To Close The Women’s Health Gap - Citeline News & Insights

Deliberate Market Building Is Next Step To Close The Women’s Health Gap Citeline News & Insights

Two Weeks Remain To Book Your Place At Industry Awards - Citeline News & Insights

Two Weeks Remain To Book Your Place At Industry Awards Citeline News & Insights

US FDA Cancer Reviewers Heading For The Exits, Potentially Impacting Review Timelines - Citeline News & Insights

US FDA Cancer Reviewers Heading For The Exits, Potentially Impacting Review Timelines Citeline News & Insights

When VC Steps Back: Finding Alternative Biotech Funding - Citeline News & Insights

When VC Steps Back: Finding Alternative Biotech Funding Citeline News & Insights

How Blood-Based Biomarkers Are Transforming Alzheimer’s Clinical Research And Patient Care - Citeline News & Insights

How Blood-Based Biomarkers Are Transforming Alzheimer’s Clinical Research And Patient Care Citeline News & Insights

Women’s Health: Tranexamic Acid Now Available OTC In France - Citeline News & Insights

Women’s Health: Tranexamic Acid Now Available OTC In France Citeline News & Insights

New US FDA CDER Director Pledges No Politics In Approvals, Adds Higher Ups Can Overturn - Citeline News & Insights

New US FDA CDER Director Pledges No Politics In Approvals, Adds Higher Ups Can Overturn Citeline News & Insights

Merck & Co.’s Winrevair Growing Into The Revenue Driver Needed Post-Keytruda LOE - Citeline News & Insights

Merck & Co.’s Winrevair Growing Into The Revenue Driver Needed Post-Keytruda LOE Citeline News & Insights

Ketryx Wants Its Validated AI Agents To Accelerate Compliance Workflows - Citeline News & Insights

Ketryx Wants Its Validated AI Agents To Accelerate Compliance Workflows Citeline News & Insights

The World’s Top 100 Pharma Companies: 2024 Sales Rankings - Citeline News & Insights

The World’s Top 100 Pharma Companies: 2024 Sales Rankings Citeline News & Insights

Breaking: Paul Offit No Longer Member Of US FDA’s Vaccine Advisory Panel - Citeline News & Insights

Breaking: Paul Offit No Longer Member Of US FDA’s Vaccine Advisory Panel Citeline News & Insights

PBMs No Longer Profit From Rebates But Plans Benefit; Should Sponsors Push More For Reform? - Citeline News & Insights

PBMs No Longer Profit From Rebates But Plans Benefit; Should Sponsors Push More For Reform? Citeline News & Insights

China Still ‘Attractive’ For Danaher Despite $50M VBP Drag - Citeline News & Insights

China Still ‘Attractive’ For Danaher Despite $50M VBP Drag Citeline News & Insights

Xbrane Sees Strategic Opening For US Ranibizumab After Sandoz Withdrawal - Citeline News & Insights

Xbrane Sees Strategic Opening For US Ranibizumab After Sandoz Withdrawal Citeline News & Insights

Citeline Launches AI Importer to Optimize Global Clinical Trial Disclosure Workflows - PharmiWeb.com

Citeline Launches AI Importer to Optimize Global Clinical Trial Disclosure Workflows PharmiWeb.com

‘Highly Problematic’: Acting FDA Commissioner Paused Planned OK Of Novavax Shot - Citeline News & Insights

‘Highly Problematic’: Acting FDA Commissioner Paused Planned OK Of Novavax Shot Citeline News & Insights

Publisher’s Spotlight: The Citeline Awards Are Open For Entries! - Citeline News & Insights

Publisher’s Spotlight: The Citeline Awards Are Open For Entries! Citeline News & Insights

Dr Reddy’s Begins OTC Expansion In Germany With Nicotinell - Citeline News & Insights

Dr Reddy’s Begins OTC Expansion In Germany With Nicotinell Citeline News & Insights

AI In Drug Discovery: The Patent Implications - Citeline News & Insights

AI In Drug Discovery: The Patent Implications Citeline News & Insights

FDA Signals Shift In Thinking On Biosimilar Trials - Citeline News & Insights

FDA Signals Shift In Thinking On Biosimilar Trials Citeline News & Insights

Podcast: OSE Immunotherapeutics’ CEO On Ulcerative Colitis Asset - Citeline News & Insights

Podcast: OSE Immunotherapeutics’ CEO On Ulcerative Colitis Asset Citeline News & Insights

Merck’s Keytruda Gains Medicare Negotiation Reprieve With Expanded Orphan Exemption - Citeline News & Insights

Merck’s Keytruda Gains Medicare Negotiation Reprieve With Expanded Orphan Exemption Citeline News & Insights

Lilly’s Price Deal For Mounjaro In UK A Harbinger Of The MFN Future? - Citeline News & Insights

Lilly’s Price Deal For Mounjaro In UK A Harbinger Of The MFN Future? Citeline News & Insights

Scrip Asks... What Does 2025 Hold For Biopharma? Part 4: Artificial Intelligence and Data Science - Citeline News & Insights

Scrip Asks... What Does 2025 Hold For Biopharma? Part 4: Artificial Intelligence and Data Science Citeline News & Insights

Baxdrostat, AstraZeneca’s Next Big CVRM Bet - Citeline News & Insights

Baxdrostat, AstraZeneca’s Next Big CVRM Bet Citeline News & Insights

The Future Of AI And Data Science In Pharma: 2025 And Beyond - Citeline News & Insights

The Future Of AI And Data Science In Pharma: 2025 And Beyond Citeline News & Insights

Big Top-Level Shifts At Sun: Ganorkar Is MD, Ex-Takeda Exec To Helm US Business - Citeline News & Insights

Big Top-Level Shifts At Sun: Ganorkar Is MD, Ex-Takeda Exec To Helm US Business Citeline News & Insights

UK’s International Recognition Procedure: EU Dossier Faster Than US Or Canada - Citeline News & Insights

UK’s International Recognition Procedure: EU Dossier Faster Than US Or Canada Citeline News & Insights

No Knife, No Burn, Just Bubbles: HistoSonics Hits 90% Tumor Control In #HOPE4Liver Trial, Eyes IPO Timing - Citeline News & Insights

No Knife, No Burn, Just Bubbles: HistoSonics Hits 90% Tumor Control In #HOPE4Liver Trial, Eyes IPO Timing Citeline News & Insights

US FDA Restructuring May Be Next After Drugs Center Loses More Than 1,000 People - Citeline News & Insights

US FDA Restructuring May Be Next After Drugs Center Loses More Than 1,000 People Citeline News & Insights

Scrip Asks… What Does 2025 Hold For Biopharma? Part 1: The State Of The Biopharma Industry - Citeline News & Insights

Scrip Asks… What Does 2025 Hold For Biopharma? Part 1: The State Of The Biopharma Industry Citeline News & Insights

Kabi Lines Up Denosumab Biosimilar Launch As FDA Says Yes To Filings - Citeline News & Insights

Kabi Lines Up Denosumab Biosimilar Launch As FDA Says Yes To Filings Citeline News & Insights

Glenmark Eyes Generic Flovent Launch In Coming Months Amid Expected US Resurgence - Citeline News & Insights

Glenmark Eyes Generic Flovent Launch In Coming Months Amid Expected US Resurgence Citeline News & Insights

US FDA Advisory Committee Freeze Raises Concerns Of Delayed, More Controversial Approvals - Citeline News & Insights

US FDA Advisory Committee Freeze Raises Concerns Of Delayed, More Controversial Approvals Citeline News & Insights

CES 2025: Scouting Digital Health Floor With Deloitte Analysts To Discover Emerging Trends - Citeline News & Insights

CES 2025: Scouting Digital Health Floor With Deloitte Analysts To Discover Emerging Trends Citeline News & Insights

Alternatives to Animal Testing: A Tech Run-Down - Citeline News & Insights

Alternatives to Animal Testing: A Tech Run-Down Citeline News & Insights

Major AI-Pharma Partnerships And Investments Of 2024: A Strategic Overview - Citeline News & Insights

Major AI-Pharma Partnerships And Investments Of 2024: A Strategic Overview Citeline News & Insights

US FDA Acting Commissioner Tells Staff She’s Ready To MAHA - Citeline News & Insights

US FDA Acting Commissioner Tells Staff She’s Ready To MAHA Citeline News & Insights

Podium Finish: US FDA’s 61 Novel Approvals In 2024 Fall Short Of 2023 Peak But Exceed Average - Citeline News & Insights

Podium Finish: US FDA’s 61 Novel Approvals In 2024 Fall Short Of 2023 Peak But Exceed Average Citeline News & Insights

Gene Editing Therapy Casgevy Now Funded In 8 Countries But French Access Withdrawn - Citeline News & Insights

Gene Editing Therapy Casgevy Now Funded In 8 Countries But French Access Withdrawn Citeline News & Insights

Citeline’s Scrip Awards 20th anniversary – here are the winners! - mva.org

Citeline’s Scrip Awards 20th anniversary – here are the winners! mva.org

US FDA Generic Drug Approvals, Other Actions Declined As Approval Times Climbed In FY 2024 - Citeline News & Insights

US FDA Generic Drug Approvals, Other Actions Declined As Approval Times Climbed In FY 2024 Citeline News & Insights

The Future Of Inflammation: The Inflammasome And Beyond - Citeline News & Insights

The Future Of Inflammation: The Inflammasome And Beyond Citeline News & Insights

Pink Sheet | Key Regulatory and Policy Insights - Citeline News & Insights

Pink Sheet | Key Regulatory and Policy Insights Citeline News & Insights

Trump’s US FDA User Fee Cycle: ‘An Underappreciated Threat’ - Citeline News & Insights

Trump’s US FDA User Fee Cycle: ‘An Underappreciated Threat’ Citeline News & Insights

The Life Of A Blockbuster - Citeline News & Insights

The Life Of A Blockbuster Citeline News & Insights

New EMA Fees Could Shake Up Pharma Submission Strategies - Citeline News & Insights

New EMA Fees Could Shake Up Pharma Submission Strategies Citeline News & Insights

US FDA Biologics Designation As Price Protection: Lilly Charts New Course With Retatrutide - Citeline News & Insights

US FDA Biologics Designation As Price Protection: Lilly Charts New Course With Retatrutide Citeline News & Insights

Gene Therapies: CoGenT Pilot Could Help With Regulatory Convergence Earlier In Development - Citeline News & Insights

Gene Therapies: CoGenT Pilot Could Help With Regulatory Convergence Earlier In Development Citeline News & Insights

BIOSECURE Act: Pfizer To Lilly - Where Are The Likely Sourcing Gaps? - Citeline News & Insights

BIOSECURE Act: Pfizer To Lilly - Where Are The Likely Sourcing Gaps? Citeline News & Insights

Generics Bulletin’s Top 50 Ranking For 2024 - Citeline News & Insights

Generics Bulletin’s Top 50 Ranking For 2024 Citeline News & Insights

Will AI Expertise Push Canada Forward As A Biopharma Hub? - Citeline News & Insights

Will AI Expertise Push Canada Forward As A Biopharma Hub? Citeline News & Insights

The Power Of AI To Map The Patient Journey - Citeline News & Insights

The Power Of AI To Map The Patient Journey Citeline News & Insights

Sandoz, Adalvo And Eurofarma Celebrate Multiple Wins At GGB Awards - Citeline News & Insights

Sandoz, Adalvo And Eurofarma Celebrate Multiple Wins At GGB Awards Citeline News & Insights

APAC As A Clinical Trial Powerhouse - Citeline News & Insights

APAC As A Clinical Trial Powerhouse Citeline News & Insights

European First As Vertex’s CRISPR/Cas9 Gene Therapy Casgevy Gets English Funding - Citeline News & Insights

European First As Vertex’s CRISPR/Cas9 Gene Therapy Casgevy Gets English Funding Citeline News & Insights

Don’t Call It Project Orbis: CoGenT Global Will Pilot Collaborative Review Of Gene Therapies - Citeline News & Insights

Don’t Call It Project Orbis: CoGenT Global Will Pilot Collaborative Review Of Gene Therapies Citeline News & Insights

Aduhelm’s Goodbye: ENVISION Confirmatory Study To End In May, With BLA Withdrawal In November - Citeline News & Insights

Aduhelm’s Goodbye: ENVISION Confirmatory Study To End In May, With BLA Withdrawal In November Citeline News & Insights

Omar Ishrak’s SPAC Buys Allurion To Support Weight-Loss System - Citeline News & Insights

Omar Ishrak’s SPAC Buys Allurion To Support Weight-Loss System Citeline News & Insights

Medicare-Negotiated Drugs May Not Get Favorable Coverage In Part D: Will CMS Intervene? - Citeline News & Insights

Medicare-Negotiated Drugs May Not Get Favorable Coverage In Part D: Will CMS Intervene? Citeline News & Insights

J&J Interested In ‘Differentiated’ Obesity Assets - Citeline News & Insights

J&J Interested In ‘Differentiated’ Obesity Assets Citeline News & Insights

Titans Of Pharma: J&J Back On Top For CEO Remuneration - Citeline News & Insights

Titans Of Pharma: J&J Back On Top For CEO Remuneration Citeline News & Insights

Duo Falter Again On US Belbuca ANDA, Eight Years After Joining Hands - Citeline News & Insights

Duo Falter Again On US Belbuca ANDA, Eight Years After Joining Hands Citeline News & Insights

Obesity Drugs Will Get Broad Commercial Coverage In 2025 Despite Cost Concerns, Survey Says - Citeline News & Insights

Obesity Drugs Will Get Broad Commercial Coverage In 2025 Despite Cost Concerns, Survey Says Citeline News & Insights

Pharma Intelligence Unveils Its Rebrand to Citeline Following Transition to Independent Company - GlobeNewswire

Pharma Intelligence Unveils Its Rebrand to Citeline Following Transition to Independent Company GlobeNewswire

J&J’s Nicorette Becomes World’s First Licensed Vaping And Smoking Cessation Therapy - Citeline News & Insights

J&J’s Nicorette Becomes World’s First Licensed Vaping And Smoking Cessation Therapy Citeline News & Insights

Celebrity Beauty Revenues Soar 58% In 2023, With Rihanna Reigning Again - Citeline News & Insights

Celebrity Beauty Revenues Soar 58% In 2023, With Rihanna Reigning Again Citeline News & Insights

Relief For Excedrin Migraine, Green For Package - Citeline News & Insights

Relief For Excedrin Migraine, Green For Package Citeline News & Insights

Top Citeline Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant